Axolabs Overview
- Year Founded
-
2000

- Status
-
Acquired/Merged
- Employees
-
40

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Axolabs General Information
Description
Developer of therapeutic nucleic acids catering to the oligonucleotide therapeutics market. The company's line of services includes lead identification, cell-based assays, protein analysis, bioanalytics, manufacturing, bioinformatics, function delivery and gene editing.
Contact Information
Website
www.axolabs.com
Formerly Known As
Roche Kulmbach, Ribopharma
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Fritz-Hornschuch-Straße 9
- 95326 Kulmbach
- Germany
+49 09221 000000
Axolabs Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Axolabs Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of therapeutic nucleic acids catering to the oligonucleotide therapeutics market. The company's line of servic
Drug Discovery
Kulmbach, Germany
40
As of 2017
000000000000
Axolabs Competitors (60)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
aTyr Pharma | Formerly VC-backed | San Diego, CA | 00 | 00000 | 00000000 | 00000 |
00000000 | Formerly VC-backed | San Diego, CA | 0 | 000.00 | 000000000 | 000.00 |
000000000 | Formerly VC-backed | South San Francisco, CA | 00 | 000.00 | 00000000 | 000.00 |
000000000 | Venture Capital-Backed | Austin, TX | 00 | 00000 | 00000000000 | 00000 |
00000 | Formerly PE-Backed | Thousand Oaks, CA | 00000 | 000.00 | 000000000 | 000.00 |
Axolabs Patents
Axolabs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3101867-A1 | Method for detecting oligonucleotide conjugates | Pending | 30-May-2018 | 0000000000 | |
EP-3802819-A1 | Method for detecting oligonucleotide conjugates | Pending | 30-May-2018 | 0000000000 | |
US-20210207123-A1 | Method for detecting oligonucleotide conjugates | Pending | 30-May-2018 | 0000000000 | |
CA-2976427-A1 | Simultaneous detection of oligonucleotides, a kit and a use related thereto | Active | 02-Mar-2015 | 0000000000 | |
CA-2976427-C | Simultaneous detection of oligonucleotides, a kit and a use related thereto | Active | 02-Mar-2015 | C12Q1/6816 |
Axolabs Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Friedrich Sanders | Managing Director, Finance | ||
Ingo Röhl | Managing Director, Operations | ||
Philipp Hadwiger | Managing Director, Research | ||
Roland Kreutzer Ph.D | Co-Founder |
Axolabs Signals
Axolabs Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|